XML 56 R83.htm IDEA: XBRL DOCUMENT v2.4.0.6
Supplemental guarantor financial information (Condensed consolidating statements of cash flows) (Details) (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Dec. 31, 2011
Dec. 31, 2010
Dec. 31, 2009
Condensed Consolidating Statement of Cash Flows [Abstract]      
Net Cash (Used) Provided By Operating Activities of Continuing Operations $ 235,367 $ 212,615 $ 206,438
Cash Flows From Investing Activities:      
Purchases of capital assets (35,506) (43,932) (44,266)
Payments for acquisitions, net of cash acquired (85,641) (98,621) (30,825)
Payments on company-owned life insurance policies (6,383) 0 0
Loans to distributors (5,175) 0 0
Purchases of marketable securities (18) (14) (4,581)
Purchases of customer lists 0 (265) (1,639)
Proceeds from sales of marketable securities 0 1,970 914
Proceeds from company-owned life insurance policies 0 6,143 0
Other 938 (1,451) (1,391)
Net cash used by investing activities of continuing operations (131,785) (136,170) (81,788)
Cash Flows From Financing Activities:      
Net payments on short-term debt (7,000) (19,000) (52,000)
Payments on long-term debt, including costs of debt reacquisition (215,030) 0 (22,627)
Proceeds from issuing long-term debt 200,000 0 0
Payments for debt issue costs (3,513) (2,361) 0
Change in book overdrafts (136) (693) (3,360)
Proceeds from issuing shares under employee plans 7,671 3,267 1,972
Excess tax benefit from share-based employee awards 1,052 680 68
Payments for common shares repurchased (23,620) (2,999) (1,319)
Cash dividends paid to shareholders (51,126) (51,435) (51,279)
Advances from (to) consolidated subsidiaries 0 0 0
Net cash used by financing activities of continuing operations (91,702) (72,541) (128,545)
Effect Of Exchange Rate Change on Cash (576) 690 1,594
Cash Used By Operating Activities Of Discontinued Operations 0 0 (470)
Cash Used By Investing Activities Of Discontinued Operations 0 0 (30)
Net Change In Cash And Cash Equivalents 11,304 4,594 (2,801)
Cash And Cash Equivalents: Beginning Of Year 17,383 12,789 15,590
Cash And Cash Equivalents: End Of Year 28,687 17,383 12,789
Senior notes due 2019 [Member]
     
Debt Instrument [Line Items]      
Parent company's ownership interest in guarantor subsidiaries (in hundredths) 100.00%    
Deluxe Corporation [Member]
     
Condensed Consolidating Statement of Cash Flows [Abstract]      
Net Cash (Used) Provided By Operating Activities of Continuing Operations 2,567 (16,786) (9,287)
Cash Flows From Investing Activities:      
Purchases of capital assets 0 0 0
Payments for acquisitions, net of cash acquired 0 0 0
Payments on company-owned life insurance policies 0    
Loans to distributors 0    
Purchases of marketable securities 0   0
Purchases of customer lists     0
Proceeds from sales of marketable securities     0
Proceeds from company-owned life insurance policies   5,782  
Other (342) (1,410) (1,234)
Net cash used by investing activities of continuing operations (342) 4,372 (1,234)
Cash Flows From Financing Activities:      
Net payments on short-term debt (7,000) (19,000) (52,000)
Payments on long-term debt, including costs of debt reacquisition (215,030)   (21,187)
Proceeds from issuing long-term debt 200,000    
Payments for debt issue costs (3,513) (2,361)  
Change in book overdrafts 742 (1,090) (3,457)
Proceeds from issuing shares under employee plans 7,671 3,267 1,972
Excess tax benefit from share-based employee awards 1,052 680 68
Payments for common shares repurchased (23,620) (2,999) (1,319)
Cash dividends paid to shareholders (51,126) (51,435) (51,279)
Advances from (to) consolidated subsidiaries 88,449 85,824 136,956
Net cash used by financing activities of continuing operations (2,375) 12,886 9,754
Effect Of Exchange Rate Change on Cash 0 0 0
Cash Used By Operating Activities Of Discontinued Operations     0
Cash Used By Investing Activities Of Discontinued Operations     0
Net Change In Cash And Cash Equivalents (150) 472 (767)
Cash And Cash Equivalents: Beginning Of Year 3,197 2,725 3,492
Cash And Cash Equivalents: End Of Year 3,047 3,197 2,725
Guarantor Subsidiaries [Member]
     
Condensed Consolidating Statement of Cash Flows [Abstract]      
Net Cash (Used) Provided By Operating Activities of Continuing Operations 213,999 224,279 217,167
Cash Flows From Investing Activities:      
Purchases of capital assets (33,731) (43,005) (41,777)
Payments for acquisitions, net of cash acquired (80,486) (98,621) (30,825)
Payments on company-owned life insurance policies (6,383)    
Loans to distributors (4,879)    
Purchases of marketable securities 0   0
Purchases of customer lists   (70) (1,639)
Proceeds from sales of marketable securities     0
Proceeds from company-owned life insurance policies   361  
Other 850 (41) (157)
Net cash used by investing activities of continuing operations (124,629) (141,376) (74,398)
Cash Flows From Financing Activities:      
Net payments on short-term debt 0 0 0
Payments on long-term debt, including costs of debt reacquisition 0   (1,440)
Proceeds from issuing long-term debt 0    
Payments for debt issue costs 0 0  
Change in book overdrafts (878) 397 97
Proceeds from issuing shares under employee plans 0 0 0
Excess tax benefit from share-based employee awards 0 0 0
Payments for common shares repurchased 0 0 0
Cash dividends paid to shareholders 0 0 0
Advances from (to) consolidated subsidiaries (87,653) (83,114) (140,965)
Net cash used by financing activities of continuing operations (88,531) (82,717) (142,308)
Effect Of Exchange Rate Change on Cash 0 0 0
Cash Used By Operating Activities Of Discontinued Operations     (470)
Cash Used By Investing Activities Of Discontinued Operations     (30)
Net Change In Cash And Cash Equivalents 839 186 (39)
Cash And Cash Equivalents: Beginning Of Year 683 497 536
Cash And Cash Equivalents: End Of Year 1,522 683 497
Non-Guarantor Subsidiaries [Member]
     
Condensed Consolidating Statement of Cash Flows [Abstract]      
Net Cash (Used) Provided By Operating Activities of Continuing Operations 18,801 5,122 (1,442)
Cash Flows From Investing Activities:      
Purchases of capital assets (1,775) (927) (2,489)
Payments for acquisitions, net of cash acquired (5,155) 0 0
Payments on company-owned life insurance policies 0    
Loans to distributors (296)    
Purchases of marketable securities (18) (14) (4,581)
Purchases of customer lists   (195) 0
Proceeds from sales of marketable securities   1,970 914
Other 430   0
Net cash used by investing activities of continuing operations (6,814) 834 (6,156)
Cash Flows From Financing Activities:      
Net payments on short-term debt 0 0 0
Payments on long-term debt, including costs of debt reacquisition 0   0
Proceeds from issuing long-term debt 0    
Payments for debt issue costs 0 0  
Change in book overdrafts 0 0 0
Proceeds from issuing shares under employee plans 0 0 0
Excess tax benefit from share-based employee awards 0 0 0
Payments for common shares repurchased 0 0 0
Cash dividends paid to shareholders 0 0 0
Advances from (to) consolidated subsidiaries (796) (2,710) 4,009
Net cash used by financing activities of continuing operations (796) (2,710) 4,009
Effect Of Exchange Rate Change on Cash (576) 690 1,594
Cash Used By Operating Activities Of Discontinued Operations     0
Cash Used By Investing Activities Of Discontinued Operations     0
Net Change In Cash And Cash Equivalents 10,615 3,936 (1,995)
Cash And Cash Equivalents: Beginning Of Year 13,503 9,567 11,562
Cash And Cash Equivalents: End Of Year $ 24,118 $ 13,503 $ 9,567